A positive serum pregnancy test in a patient on the potent teratogen lenalidomide: a distressing result provides a valuable learning opportunity

Int J Dermatol. 2021 Mar;60(3):e96-e98. doi: 10.1111/ijd.15197. Epub 2020 Sep 29.
No abstract available

Publication types

  • Letter

MeSH terms

  • Abnormalities, Drug-Induced* / etiology
  • Female
  • Humans
  • Lenalidomide / adverse effects
  • Pregnancy
  • Pregnancy Tests*
  • Teratogens

Substances

  • Teratogens
  • Lenalidomide